Roy D. Baynes, Director: Travere Therapeutics TVTX Planned sale · Filed 04/06

Trade details

Type: Planned sale notice
Stock: Travere Therapeutics TVTX
Person: Roy D. BaynesDirector
Planned sale date: 26/04/06
Filed: 26/04/06

$330K to be sold

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 03/07~05/06

Roy D. Baynes's recent trades

Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/16
Traded 06/12
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$225K
4,500 sh
$225K
Filed 06/12
Traded 06/12
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/06
Traded 05/05
Roy D. BaynesDirector
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$209.9K
4,500 sh
$209.9K
Filed 05/05
Traded 05/05
Roy D. BaynesDirector
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$431.1K
9,750 sh
$431.1K
Filed 05/04
Traded 05/01

Roy D. Baynes, Director — plans to sell 10,000 sh of Travere Therapeutics TVTX · $330K · around 04/06 · 10b5-1 plan | Whalegun